tiprankstipranks
Advertisement
Advertisement
Sionna Therapeutics files automatic mixed securities shelf
PremiumThe FlySionna Therapeutics files automatic mixed securities shelf
1M ago
Sionna Therapeutics reports Q4 EPS (46c), consensus (55c)
Premium
The Fly
Sionna Therapeutics reports Q4 EPS (46c), consensus (55c)
1M ago
Sionna Therapeutics initiated with an Outperform at Citizens
Premium
The Fly
Sionna Therapeutics initiated with an Outperform at Citizens
1M ago
Sionna Therapeutics initiated with an Outperform at LifeSci Capital
PremiumThe FlySionna Therapeutics initiated with an Outperform at LifeSci Capital
4M ago
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
Premium
Ratings
Sionna Therapeutics: NBD1-Targeted CFTR Stabilization Strategy Positions Pipeline for Best-in-Class Efficacy and Blockbuster Upside in Cystic Fibrosis
4M ago
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
Premium
The Fly
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
4M ago
Sionna Therapeutics Advances CF Pipeline Amid Strong Financials
PremiumCompany AnnouncementsSionna Therapeutics Advances CF Pipeline Amid Strong Financials
5M ago
Sionna Therapeutics reports Q3 EPS (46c), consensus (47c)
Premium
The Fly
Sionna Therapeutics reports Q3 EPS (46c), consensus (47c)
5M ago
Sionna Therapeutics expects cash to fund operations into 2028
Premium
The Fly
Sionna Therapeutics expects cash to fund operations into 2028
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100